* Enfusion Inc ENFN.N ENFN.K is expected to show a rise
in
quarterly revenue when it reports results on November 10.
* The Chicago Illinois-based company is expected to report
a
32.7% increase in revenue to $38.539 million from $29.05 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Enfusion Inc is for
earnings of 2 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Enfusion
Inc is
$13, above its last closing price of $12.59.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 0.02 0.02 0.06 Beat 200
Mar. 31 2022 0.03 0.03 0.07 Beat 124.8
Dec. 31 2021 0.03 0.04 0.02 Missed -43.6
Sep. 30 2021 0.04 0.04 0.03 Missed -18.9
This summary was machine generated November 9 at 00:51 GMT. All
figures in US dollars unless otherwise stated